Celon Pharma S.A.
CLN
Rank in Stocks
#16275
Celon Pharma S.A. operates as a fully-integrated pharmaceutical firm,... Celon Pharma S.A. operates as a fully-integrated pharmaceutical firm, undertaking the investigation, development, production, and distribution of diverse medicinal formulations. Its business model is structured around two principal areas: generic drug offerings and innovative therapeutic solutions. The company's product line addresses a range of health challenges, including oncological conditions, neurological disorders, diabetes, and other metabolic complaints. Established in 2002, this enterprise is situated in Lomianki, Poland, and functions as a subsidiary of Glatton Sp. z o.o.
Share Price
$4.02
Last synced: 2026-11-12
Market Cap
$216.94M
Change (1 day)
-3.51%
Change (1 year)
-32.26%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Celon Pharma S.A. (CLN)
Category
Healthcare
Operating Margin for Celon Pharma S.A. (CLN)
Operating Margin as of November 2026 TTM: -11.78%
According to Celon Pharma S.A.'s latest financial reports, its current operating margin (TTM) is -11.78%. At the end of 2025 the company had an operating margin of -27.06%.
Operating Margin history for Celon Pharma S.A. from 2012 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -11.78% | -56.47% |
| 2025 | -27.06% | 29.85% |
| 2024 | -20.84% | 63.71% |
| 2023 | -12.73% | -70.45% |
| 2022 | -43.08% | 708.26% |
| 2021 | -5.33% | 128.76% |
| 2020 | -2.33% | -134.52% |
| 2019 | 6.75% | -76.26% |
| 2018 | 28.43% | 17.19% |
| 2017 | 24.26% | -33.61% |
| 2016 | 36.54% | -16.75% |
| 2015 | 43.89% | 47.38% |
| 2014 | 29.78% | -2.87% |
| 2013 | 30.66% | 431.37% |
| 2012 | 5.77% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.69% | -101.67% |
DE
|
|
| 19.68% | -101.67% |
DE
|
|
| 13.26% | -101.13% |
JP
|
|
| 17.08% | -101.45% |
CH
|
|
| 10.53% | -100.89% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Celon Pharma S.A.'s operating margin
What is Celon Pharma S.A.'s operating margin?
Celon Pharma S.A.'s operating margin is -11.78%, as of Nov 2026.
What was Celon Pharma S.A.'s operating margin in 2025?
In 2025, Celon Pharma S.A.'s operating margin was -27.06%, compared with -20.84% in 2024.
How has Celon Pharma S.A.'s operating margin changed since 2020?
From 2020 to 2025, Celon Pharma S.A.'s operating margin was highest in 2020 (-2.33%) and lowest in 2022 (-43.08%).
How does Celon Pharma S.A.'s operating margin compare with similar companies?
Celon Pharma S.A.'s operating margin (-11.78%) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.